Sato Sakura, Yanagida Noriyuki, Nagakura Ken-Ichi, Takahashi Kyohei, Borres Magnus P, Ebisawa Motohiro
Department of Allergy, Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Kanagawa, Japan.
Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
World Allergy Organ J. 2024 Nov 20;17(12):101001. doi: 10.1016/j.waojou.2024.101001. eCollection 2024 Dec.
The clinical importance of sensitization to 6 (Ara h 6) in Japanese children remains unelucidated. We aimed to quantitatively evaluate the clinical importance of sensitization to Ara h 6 in managing peanut allergy in Japanese children.
We retrospectively analyzed the data of children with or without symptoms induced by an oral food challenge or home dosing of up to 3 g of peanuts. The specific immunoglobulin E (sIgE) levels against peanuts, Ara h 2, and Ara h 6 were quantified using an ImmunoCAP assay.
We examined 273 patients aged 4.6-9.8 years (median 6.3); 189 (69%) were male, 187 (68%) had allergies to peanuts, and 43 (16%) had anaphylactic reactions to peanuts. Ara h 6 and Ara h 2 co-sensitization was observed in 224 patients (82%). Ara h 6-sIgE levels were significantly associated with the probability of allergic reactions and anaphylaxis. The 95% probability of allergic reactions to peanuts was obtained at 44.5 kU/L of Ara h 6-sIgE, but the 95% probability of anaphylaxis could not be calculated. A combination of Ara h 6 and Ara h 2 could not improve diagnostic accuracy for allergic reactions and anaphylaxis to peanuts.
Sensitization to Ara h 6 played an important role in managing peanut allergy in Japanese children, and sIgE levels provided valuable predictive information for allergic reactions to peanuts. However, the measurement of Ara h 6 did not improve the diagnostic accuracy of anaphylaxis, and Ara h 2 alone might be sufficient for clinical evaluation in peanut allergy.
在日本儿童中,对花生过敏原Ara h 6致敏的临床重要性仍不明确。我们旨在定量评估对Ara h 6致敏在日本儿童花生过敏管理中的临床重要性。
我们回顾性分析了经口服食物激发试验或在家中摄入高达3克花生后出现或未出现症状的儿童数据。使用免疫捕获法对针对花生、Ara h 2和Ara h 6的特异性免疫球蛋白E(sIgE)水平进行定量。
我们检查了273名年龄在4.6至9.8岁(中位数6.3岁)的患者;189名(69%)为男性,187名(68%)对花生过敏,43名(16%)对花生有过敏反应。224名患者(82%)观察到Ara h 6和Ara h 2共同致敏。Ara h 6-sIgE水平与过敏反应和过敏休克的可能性显著相关。Ara h 6-sIgE为44.5 kU/L时,花生过敏反应的概率为95%,但过敏休克的95%概率无法计算。Ara h 6和Ara h 2联合检测不能提高花生过敏反应和过敏休克的诊断准确性。
对Ara h 6致敏在日本儿童花生过敏管理中起重要作用,sIgE水平为花生过敏反应提供了有价值的预测信息。然而,Ara h 6的检测并未提高过敏休克的诊断准确性,单独检测Ara h 2可能足以进行花生过敏的临床评估。